Cargando…
Adjuvant chemoradiotherapy after d2-lymphadenectomy for gastric cancer: the role of n-ratio in patient selection. results of a single cancer center
BACKGROUND: Adjuvant chemoradiotherapy is part of a multimodality treatment approach in order to improve survival outcomes after surgery for gastric cancer. The aims of this study are to describe the results of gastrectomy and adjuvant chemoradiotherapy in patients treated in a single institution, a...
Autores principales: | Costa, Wilson L, Coimbra, Felipe JF, Fogaroli, Ricardo C, Ribeiro, Héber SC, Diniz, Alessandro L, Begnami, Maria Dirlei FL, Mello, Celso AL, Fanelli, Marcelo F, Silva, Milton JB, Fregnani, José Humberto, Montagnini, André L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542168/ https://www.ncbi.nlm.nih.gov/pubmed/23068190 http://dx.doi.org/10.1186/1748-717X-7-169 |
Ejemplares similares
-
Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high-risk gastric cancer patients
por: Costa, Wilson L, et al.
Publicado: (2012) -
Effect of adjuvant chemoradiotherapy on overall survival of gastric cancer patients submitted to D2 lymphadenectomy
por: Jácome, Alexandre A. A., et al.
Publicado: (2012) -
Pancreatic mucinous cystadenoma with serum CA 19–9 over 1,000,000 U/mL: a case report and review of the literature
por: Costa, Wilson L, et al.
Publicado: (2015) -
Prognostic implications of phosphatidylinositol 3-kinase/AKT signaling pathway activation in gastric carcinomas
por: Chiappini, Paula Blandina Ola, et al.
Publicado: (2016) -
Cost-effectiveness of para-aortic lymphadenectomy before chemoradiotherapy in locally advanced cervical cancer
por: Lee, Jung-Yun, et al.
Publicado: (2015)